Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Men with Prostate Cancer Worse off than Women with Breast Cancer


Maintaining lifestyle top of men’s list when choosing a prostate cancer therapy

Despite wanting to avoid undesirable side effects, nearly half of men with prostate cancer do not have enough information on the lifestyle impact of treatments

Nearly nine out of 10 healthy men say maintaining their lifestyle is the main priority if they had to receive a hormonal treatment for locally advanced prostate cancer, according to a new study.1 In reality, nearly half of men feel that they are not asked about their lifestyle preferences when discussing treatment options and their effect on quality of life, as results from a new patient survey show.2 In contrast, more than three quarters of women with breast cancer are likely to be asked about their lifestyle preferences when discussing treatment options.2

The study involved 180 healthy men, aged 50 years and over, who were given scenarios describing the details of the two types of hormonal therapies used in locally advanced prostate cancer - either a luteinising hormone releasing analogue (LHRHa), or a non-steroidal anti-androgen (NSAA), such as bicalutamide 150mg – together with a discussion on their side effects. They were then interviewed and asked which type of therapy they would prefer if they were diagnosed with locally advanced prostate cancer.

Professor Lesley Fallowfield, one of the study researchers and Director of Cancer Research UK’s Psychosocial Oncology Group, Brighton and Sussex Medical School, says: “These results suggest that men with locally advanced prostate cancer should be offered not just a choice of treatment but an explanation of how the treatments are given and the impact that their side effects may have on men’s lifestyles.”

Most men would prefer a hormonal therapy that allows them to maintain their lifestyle by avoiding undesirable side effects, such as reduced physical strength and increased risk of bone fractures. Nearly nine out of 10 men say they would prefer NSAA therapy (compared with less than one in 10 choosing an LHRHa), because of a better side effect profile (three quarters of respondents).

Patients with locally advanced prostate cancer have a significant risk of their disease progressing, seriously impacting quality of life. Therefore therapies that improve progression-free survival whilst allowing patients to maintain a normal lifestyle are vital in managing the disease. It has been shown that when patients’ are given the advantages and disadvantages of alternative treatments, they are willing to contemplate trading life expectancy to be relieved of the burden of side effects, such as limitations in physical energy.3

In addition, results from the patient survey show the need for physicians to involve men more when deciding on the choice of treatment. The comparative survey of prostate (n=87) and breast (n=104) cancer patients currently receiving hormonal therapy aimed to look at the differences in behavioural and attitudinal approaches that men and women have towards their disease and its treatment. Findings show that just over half of men with prostate cancer are likely to be asked about their lifestyle preferences by their physician in stark contrast to four out of five women with breast cancer when treatment options are being discussed.2

“Although men are traditionally less likely to talk about illness, especially their own,” says Professor John Masters, Executive Director, the Prostate Cancer Research Centre, University College, London. “These findings show us that not enough is being done to address men’s concerns over side effects of prostate cancer therapies and their impact on lifestyle. Patients need to be involved in the treatment decision process to ensure that they receive the best treatment choice in terms of lifestyle and quality of life.”

Even though nearly two thirds of men with prostate cancer experience side effects with hormonal therapies, less than one in five is willing to discuss the possibility of changing treatment to reduce side effects, compared with more than a third of women with breast cancer.2

Mr Geoffrey Mitchell, a 59-year-old grandfather of three, says that men need to be bolder when it comes to challenging their physicians about treatments and actively seeking more information about their illness. "When I was first diagnosed with prostate cancer, I felt it was very much a case of ’doctor knows best’. Also, the worry of first being told you have cancer meant I couldn’t really think straight at the time. Fortunately, my doctor discussed all the options in detail and we both agreed the most suitable drug for me. The last thing I wanted was to have to give up my active lifestyle and work. We both agreed that I needed a treatment which would mean I could still carry on at work and be there for my children and grandchildren."

The findings from both the preference study and patient survey reinforce the need to offer patients with locally advanced prostate cancer a choice of treatment options, and for physicians to discuss these not only in terms of achieving an effective outcome but also how their side effects will impact on men’s lifestyles and physical activities.

Each year around 30,000 men in the UK alone are diagnosed with prostate cancer, which has overtaken lung cancer to become the most common cancer for men in the UK. Prostate cancer is the second biggest cause of death from cancer in men in the UK with around 10,000 deaths each year and more than 80 per cent of cases are diagnosed in men over 60.4.

Rosie Allan | alfa
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

Im Focus: Radar for navigation support from autonomous flying drones

At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.

Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

International Virtual Reality Conference “IEEE VR 2018” comes to Reutlingen, Germany

08.03.2018 | Event News

Latest News

Wandering greenhouse gas

16.03.2018 | Earth Sciences

'Frequency combs' ID chemicals within the mid-infrared spectral region

16.03.2018 | Physics and Astronomy

Biologists unravel another mystery of what makes DNA go 'loopy'

16.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>